비씨월드제약 분기보고서 (2022.03)
1. 요약재무정보

당사는 주식회사의 외부감사에 관한법률 제13조 1항1호에서 규정하고 있는 국제회계기준위원회의 국제회계기준을 채택하여 정한 회계처리기준인 한국채택국제회계기준에 따라 재무제표를 작성하였습니다. 가. 연결요약재무정보

(단위 : 원)

과목	제43(당)분기	제42(전)기	제41(전전)기

2022년 3월말	2021년 12월말	2020년 12월말

[유동자산]	52,549,641,394	51,695,106,519	53,693,220,592

ㆍ당좌자산	2,942,674,254	4,502,521,874	12,560,812,998

ㆍ매출채권및기타매출	16,672,022,339	15,926,836,566	14,712,393,488

ㆍ재고자산	31,888,262,404	30,607,812,257	25,999,563,385

ㆍ기타유동자산	1,046,682,397	657,935,822	420,450,721

[비유동자산]	155,548,844,678	155,024,848,860	139,270,746,614

ㆍ투자자산	3,662,182,532	3,756,414,963	3,302,572,873

ㆍ유형자산	146,231,268,877	145,523,278,653	130,908,415,845

ㆍ무형자산	2,237,991,594	2,265,766,219	1,174,791,740

ㆍ기타비유동자산	3,417,401,675	3,479,389,025	3,884,966,156

자산총계	208,098,486,072	206,719,955,379	192,963,967,206

[유동부채]	65,617,165,675	56,764,216,342	55,518,428,637

[비유동부채]	40,097,192,000	47,118,639,804	37,197,777,228

부채총계	105,714,357,675	103,882,856,146	92,716,205,865

[지배기업지분]	103,867,159,501	104,335,106,580	101,694,175,596

ㆍ자본금	1,778,476,800	1,778,476,800	1,778,476,800

ㆍ자본잉여금	34,947,264,726	34,947,264,726	34,947,264,726

ㆍ자본조정	(771,621,170)	(771,621,170)	(771,621,170)

ㆍ기타포괄손익누계	76,044,150	248,541,317	100,654,351

ㆍ이익잉여금	67,836,994,995	68,132,444,907	65,639,400,889

[소수주주지분]	(1,483,031,104)	(1,498,007,347)	(1,446,414,255)

자본총계	102,384,128,397	102,837,099,233	100,247,761,341

구분	(2022.01.01 ~2022.03.31)	(2021.01.01 ~2021.12.31)	(2020.01.01 ~2020.12.31)

매출액	15,881,530,844	61,617,505,810	41,414,969,862

영업이익	1,062,637,282	3,368,620,098	6,615,733,869

당기순이익	573,382,831	3,019,166,406	3,194,252,372

ㆍ지배회사지분순손익	558,406,588	3,070,759,499	4,661,533,632

ㆍ소수주주지분순손익	14,976,243	(51,593,093)	(1,467,281,260)

총포괄손익	794,533,045	3,443,194,389	3,781,632,119

ㆍ지배회사지분순손익	779,556,802	3,494,787,482	5,248,913,379

ㆍ소수주주지분순손익	14,976,243	(51,593,093)	(1,467,281,260)

주당순이익(원)	65	360	995

연결에 포함된 회사수	1	1	1

나. 별도요약재무정보(단위 : 원)

과목	제43(당)분기	제42(전)기	제41(전전)기

2022년 3월말	2021년 12월말	2020년 12월말

[유동자산]	53,082,144,675	53,054,051,117	56,636,624,601

ㆍ당좌자산	2,870,559,478	4,306,087,488	11,180,509,978

ㆍ매출채권및기타매출	19,990,708,925	19,695,344,344	21,456,453,487

ㆍ재고자산	28,007,103,753	28,549,430,750	23,812,093,951

ㆍ기타유동자산	2,213,772,519	503,188,535	187,567,185

[비유동자산]	123,310,287,534	122,396,126,822	106,109,868,339

ㆍ투자자산	3,662,182,532	3,756,414,963	3,302,572,873

ㆍ유형자산	115,890,937,924	114,909,721,180	99,429,897,155

ㆍ무형자산	2,062,844,263	2,077,095,551	1,017,857,740

ㆍ기타비유동자산	1,694,322,815	1,652,895,128	2,359,540,571

자산총계	176,392,432,209	175,450,177,939	162,746,492,940

[유동부채]	46,015,840,081	38,173,185,075	37,583,537,308

[비유동부채]	25,026,395,590	31,443,872,944	22,022,359,996

부채총계	71,042,235,671	69,617,058,019	59,605,897,304

ㆍ자본금	1,778,476,800	1,778,476,800	1,778,476,800

ㆍ자본잉여금	34,947,264,726	34,947,264,726	34,947,264,726

ㆍ자본조정	(771,621,170)	(771,621,170)	(771,621,170)

ㆍ기타포괄손익누계	76,044,150	248,541,317	100,654,351

ㆍ이익잉여금	69,320,032,032	69,630,458,247	67,085,820,929

자본총계	105,350,196,538	105,833,119,920	103,140,595,636

종속ㆍ관계ㆍ공동기업투자주식의 평가방법	지분법	지분법	지분법

구분	(2022.01.01 ~2022.03.31)	(2021.01.01 ~2021.12.31)	(2020.01.01 ~2020.12.31)

매출액	15,273,636,482	60,385,893,124	41,414,969,862

영업이익	831,714,068	4,144,346,055	6,615,733,869

당기순이익	543,430,285	3,122,352,798	6,326,463,898

기타포괄손익	221,150,214	424,027,983	587,379,747

ㆍ재분류되지 않는 손익	221,150,214	424,027,983	587,379,747

총포괄손익	764,580,499	3,546,380,781	6,695,333,419

주당순이익(원)	64	366	718